Reunión presencial

II GO NORTE INTERNATIONAL GU DEBATES

5 y 6 octubre 2023

Go Norte Grupo oncológico twentyfour bullets verdigris
5 octubre 2023
Coordinadores científicos
09.30-10.00 h - REGISTRATION
10.00 h - OPENING

Dr. Ignacio Durán, Medical Oncology Department, Hospital Universitario Marqués de Valdecilla - IDIVAL, Santander
Dr. Nuria Lainez, Medical Oncology Department, Hospital Universitario de Navarra, Pamplona

10.15-11.45 h - PERIOPERATIVE TREATMENT IN GU ONCOLOGY: THE DEBATE IS OPEN
THE CASE OF BLADDER CANCER

Chairs:
Dr. Enrique Grande, Medical Oncology Department, MD Anderson Cancer Center Madrid
Dr. Mario Álvarez Maestro, Urology Department, Hospital Universitario La Paz, Madrid

10.15-10.25 h - Questions to audience (Interactive Voting)

Perioperative treatment in MIBC: An interactive case

10.25-10.40 h - IO based perioperative treatment in muscle invasive bladder cancer: in favor

Dr. Mª José Juan, Medical Oncology Department, Instituto Valenciano de Oncología, Valencia

10.40-10.55 h - IO based perioperative treatment in muscle invasive bladder cancer: the critical approach

Dr. Alfonso Gómez de Liaño, Medical Oncology Department, Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria
Voting

10.55-11.15 h - Perioperative treatment in muscle invasive bladder cancer: the expert’s vision

Dr. Michiel Van der Heijden, Medical Oncology Department, Netherlands Cancer Institute, Amsterdam

11.15-11.45 h - Discussion
11.45-12.15 h - COFFEE BREAK
12.15-13.45 h - THE CASE OF KIDNEY CANCER

Chairs:
Dr. Pablo Maroto, Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona
Dr. Felipe Villacampa, Urology Department, Clínica Universidad de Navarra, Madrid

12.15-12.25 h - Questions to audience (Interactive Voting)

Perioperative treatment in RCC: An interactive case

12.25-12.40 h - IO based perioperative treatment in localized renal cell cancer: in favor

Dr. Javier Puente, Medical Oncology Department, Hospital Clínico San Carlos, Madrid

12.40-12.55 h - IO based perioperative treatment in localized renal cell cancer: the critical approach

Dr. Guillermo de Velasco, Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid
Voting

12.55-13.15 h - IO based perioperative treatment in localized RCC: the expert’s vision

Dr. Jens Bedke, Urology Department, Comprehensive Cancer Center Tübingen-Stuttgart

13.15-13.45 h - Discussion
13.45 -14.30 h - MEET WITH THE EXPERT SYMPOSIUM
Chair

Dr. Ignacio Durán, Medical Oncology Department, Hospital Universitario Marqués de Valdecilla - IDIVAL, Santander

BAVENCIO Meet the expert Prof Grivas: Extend overall survival in UC

Dr. Petros Grivas, Medical Oncology Department, Genitourinary Cancers Program, University of Washington, Clinical Research Division, Fred Hutchinson Cancer Center

Go Norte Grupo oncológico merck
14.30 -16.00 h - LUNCH COCKTAIL
16.00 -17.25 h - CHALLENGING STANDARDS OF CARE IN BLADDER CANCER TREATMENT

Chairs:
Dr. Daniel Castellano, Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid
Dr. Ignacio Durán, Medical Oncology Department, Hospital Universitario Marqués de Valdecilla - IDIVAL, Santander

16.00 -16.15 h - The BCG refractory scenario: are the upcoming strategies good enough to replace the standard?

Dr. Félix Guerrero, Urology Department, Hospital Universitario 12 de Octubre, Madrid

16.15 -16.35 h - Are ADCs combinations the new backbone in first-line mUC?

Dr. Petros Grivas, Medical Oncology Department, Genitourinary Cancers Program, University of Washington, Clinical Research Division, Fred Hutchinson Cancer Center

16.35 -16.55 h - Are the Galsky criteria getting old fashioned in 2023? Are we going to stratify patients in first-line in the near future?

Dr. Yohann Loriot, Medical Oncology Department, Institut Gustave Roussy, Villejuif, France

16.55 -17.25 h - Discussion
17.25-17.55 h - COFFEE BREAK
17.55 -19.25 h - THINKING OUTSIDE OF THE BOX: OPPORTUNITIES FOR COLLABORATION

Chairs:
Dr. Laura Basterretxea, Medical Oncology Department, Hospital Universitario Donostia
Dr. Ricardo Fernández, Medical Oncology Department, Instituto Oncológico IMQ Zorrotzaurre, Hospital Universitario de Cruces, Bizkaia

17.55 -18.10 h - Physical exercise and cancer: a possible duet in GU oncology?

Mr. Mario Redondo, Physiotherapist, Exercise Physiology Cancer Center, Madrid

18.10 -18.25 h - New technologies and prostate cancer patients: is it feasible?

Mr. Borja Gómez Mediavilla, Research Nurse, Instituto de Investigación Sanitaria – IDIVAL, Santander

18.25 -18.40 h - Managing elderly GU oncology patients: am I missing something?

Dr. Regina Gironés, Medical Oncology Department, Hospital Universitari i Politècnic La Fe, Valencia

18.40 -18.55 h - Oligometastatic disease in GU oncology: facts and “myths”

Dr. Alfonso Gómez de Iturriaga, Radiation Oncology Department, Hospital Universitario de Cruces, Bilbao

18.55 -19.25 h - Discussion
19.25 -20.10 h - A LOOK INTO THE NEAR FUTURE

Chair: Dr. Álvaro Pinto, Medical Oncology Department, Hospital Universitario La Paz, Madrid

Metaverso: ¿el futuro de Internet?
Mr. Mauro A. Fuentes, Digital Communication Transformation, Communication and Institutional Relations Department, CaixaBank, Madrid

20.10 -20.20 h - CLOSING OF THE DAY
21.15 - DINNER ATTENDEES
6 octubre 2023
8.30 h - OPENING

Dr. Ignacio Durán, Medical Oncology Department, Hospital Universitario Marqués de Valdecilla - IDIVAL, Santander
Dr. Nuria Lainez, Medical Oncology Department, Hospital Universitario de Navarra, Pamplona

8.35-9.45 h - ADVANCED KIDNEY CANCER: FROM THE CLINIC TO THE BASIC SCIENCE

Chairs:
Dr. Jesús García-Donas, Medical Oncology Department, Hospital Universitario HM Sanchinarro - Centro Integral Oncológico Clara Campal HM CIOCC,Madrid
Dr. Teresa Alonso, Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid

8.35-8.55 h - Certainties and doubts in first-line mRCC

Dr. Viktor Grünwald, Medical Oncology Department, University Hospital Essen, German

8.55-9.15 h - Understanding the dynamics of renal cell cancer evolution to improve therapeutics

Dr. Charlotte Spencer, Research Department of Pathology, Cancer Dynamics Laboratory, Francis Crick Institute, Renal and Skin Unit, The Royal Marsden Hospital, London

9.15-9.30 h - Characterizing rare renal cell cancers to guide treatment

Dr. Cristina Rodríguez-Antona, Established Investigator, Centro Nacional de Investigaciones Oncológicas-CNIO, Madrid

9.30-9.55 h - Discussion
9.45-11.05 h - PROSTATE CANCER: CHALLENGES IN 2023

Chairs: Dr. Joan Carles, Medical Oncology Department, Hospital Universitari Vall d’Hebron, Barcelona
Dr. Mario Domínguez, Urology Department, Hospital Universitario Marqués de Valdecilla - IDIVAL, Santander

9.45-10.00 h - PARPi: the debate is open

CPRC and PARP inhibitors: An interactive case

10.00-10.15 h - PARPi: the selection does not matter to me

Dr. David Lorente, Medical Oncology Department, Hospital Provincial de Castellón

10.15-10.30 h - PARPi: the selection does matter to me

Dr. Elena Castro, Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid
Voting

10.30-10.50 h - PARP inhibition and patient selection: integrating basic science and clinical data

Dr. Johann Sebastian de Bono, Medical Oncology Department, The Institute of Cancer Research and Royal Marsden, London, UK

10.50-11.05 h - Discussion
11.05-11.45 h - COFFEE BREAK
11.35-12.20 h - MEET WITH THE EXPERT- SYMPOSIUM
Chair

Dr. Ignacio Durán, Medical Oncology Department, Hospital Universitario Marqués de Valdecilla - IDIVAL, Santander

Paradigm shift in the adjuvant treatment of renal cancer from a multidisciplinary approach

Dr. Álvaro Pinto, Medical Oncology Department, Hospital Universitario La Paz, Madrid
Dr. Albert Francès, Urology Department, Hospital del Mar - Parc de Salut Mar, Barcelona

Go Norte Grupo oncológico MSD noclaim
12.20-13.30 h - ADVANCED HORMONE-SENSITIVE PROSTATE CANCER

Chairs:
Dr. Carmen Santander, Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza
Dr. Juan Francisco Rodríguez Moreno, Medical Oncology Department, Hospital Universitario HM Sanchinarro - Centro Integral Oncológico Clara Campal HM CIOCC, Madrid

12.20-12.35 h - A triplet is my standard of care for all mHSPC patients

Dr. Enrique González-Billalabeitia, Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid

12.35-12.50 h - I select very carefully my mHSPC patients for a triplet

Dr. Miguel Ángel Climent, Medical Oncology Department, Instituto Valenciano de Oncología, Valencia

12.50-13.10 h - Patient selection in mHSPC : Integrating current data

Dr. Bertrand Tombal, Urology Department, Université Catholique de Louvain, Belgium

13.10-13.30 h - Discussion
13.30-14.20 h - THERAGNOSIS IN PROSTATE CANCER: WHERE ARE WE IN 2023?

Chair: Dr. José Luis Pérez Gracia, Medical Oncology Department, Clínica Universidad De Navarra, Pamplona

13.30-13.45 h - What a clinician should know about PSMA PET in prostate cancer: Success and pitfalls

Dr. Antonio Maldonado, Nuclear Medicine Department, Hospital Universitario Quirónsalud Madrid

13.45-14.00 h - What can I expect from theragnosis in prostate cancer: the clinician’s perspective

Dr. Josep Mª Piulats, Medical Oncology Department, Institut Català d’Oncologia Hospital Duran i Reynals, L’Hospitalet de Llobregat

14.00-14.20 h - Discussion
14.20-14.25 h - CLOSING REMARKS
14.25 h - FAREWELL COCKTAIL

Te animamos a inscribirse mediante el enlace de registro o consultando a los patrocinadores del simposio.
Si precisas de más información, puedes contactar con la Secretaría Técnica: congresos@tacticsmd.net

 

Go Norte Grupo oncológico twentyfour bullets verdigris
ALOJAMIENTOS

Alojamientos recomendados cerca del Parador de Limpias:

Hotel Villa Pasiega * * * * (Hoznayo)

Distancia: a 20 minutos en coche del Parador de Limpias
Procedimiento reservas: Para beneficiarse del cupo reservado por GONORTE, se deberá contactar con el hotel a través de reservas@grupolospasiegos.com o bien del teléfono 942 525 962.
Referencia para la reserva: CONGRESO GO NORTE

Tarifas de habitaciones(*):
Doble 80,90€/noche – En régimen de alojamiento y desayuno.
Individual 54,50€/noche – En régimen de alojamiento y desayuno.
Incluye acceso spa y dispone de parking exterior sin coste.

*A las reservas realizadas por otro medio, incluso a través de su página web, no se les aplicará la tarifa acordada.
Página web: www.grupolospasiegos.com

Hotel Castilla Termal Solares * * * * (Solares)

Distancia: a 25 minutos en coche del Parador de Limpias
Procedimiento reservas: Para beneficiarse del cupo reservado por GONORTE, se deberá contactar con el hotel a través de recepcion.solares@castillatermal.com o bien del teléfono 942 521 313.
Referencia para la reserva: CONGRESO GO NORTE

Tarifas de habitaciones(*):
Doble: 130€/noche - En régimen de alojamiento y desayuno.
Individual: 112€/noche - En régimen de alojamiento y desayuno.

* A las reservas realizadas por otro medio, incluso a través de su página web, no se les aplicará la tarifa acordada.
Página web: www.castillatermal.com/hoteles/cantabria/castilla-termal-solares/

IMPORTANTE

Estas tarifas estarán garantizadas, identificándose como asistentes al congreso GO NORTE, para todas las reservas recibidas antes del 15 de septiembre de 2023.

Go Norte Grupo oncológico twentyfour bullets verdigris

Organizado por:

Logo GO NORTE

Patrocinadores platino:

merck
MSD-noclaim

Patrocinadores oro:

Go Norte Grupo oncológico Janssen Oncology

Patrocinadores plata:

Go Norte Grupo oncológico BMS 2022
Go Norte Grupo oncológico ADACAP
Go Norte Grupo oncológico Astellas 1
Bayer
Go Norte Grupo oncológico IPSEN

Patrocinadores bronce:

Go Norte Grupo oncológico Alianza MSD AstraZeneca3
Go Norte Grupo oncológico EusaPharma
Go Norte Grupo oncológico Roche
Go Norte Grupo oncológico Pfizer
Go Norte Grupo oncológico Gilead oncology2
Hazte socio de GO NORTE Grupo Oncológico

Dra. Nuria Laínez
Vicepresidenta GO NORTE

Hazte socio, hazte socia

En la lucha contra los tumores genitourinarios todos y todas somos necesarios.

Hazte socio de GO NORTE Grupo Oncológico

Dra. Nuria Lainez
Vicepresidenta GO NORTE

Scroll al inicio